• Physician Profile

    Lisa R. Diller, MD

    Lisa R. Diller, MD

    Top Doctor

    Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Clinical Director, Pediatric Oncology
    Medical Director, Clinical Cancer and Blood Disorders Service Line
    Medical Director, David B. Perini, Jr. Quality of Life Clinic
    Institute Physician

    Professor of Pediatrics, Harvard Medical School


    Pediatric Solid Tumors
    Pediatric Cancer Survivorship
    Pediatric Cancer Genetic Risk Program

    Office phone: 617-632-5642
    Appointment phone: 888-733-4662 (new); 617-632-3270 (established)
    Fax: 617-582-9049
    Email: lisa_diller@dfci.harvard.edu

    Preferred contact method: office phone
    Request an appointment

    View Researcher Profile


    Pediatric Hematology/Oncology

    Research Department

    Pediatric Oncology


    Late effects of pediatric cancer, Retinoblastoma, Solid tumors, Wilms tumor, Neuroblastoma, Cancer predisposition, Melanoma, Global health

    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215


    Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Boston Children's Hospital/Dana-Farber Institute where she has been on the faculty for more than 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.


    Board Certification
    Pediatric Hematology/Oncology

    Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 07/88 to 06/91

    Boston Children's Hospital, Pediatrics, 07/86 to 06/88

    Children's Hospital Boston, 07/85 to 06/86

    Medical School
    University of California, San Diego School of Medicine, 1985

    Recent Awards

    • Stephen E. Sallan Leadership award, 2004
    • Benacerraf-Frei Investigator, DFCI, 1998
    • Dyson Scholar Award, DFCI, 1998
View Researcher Directory
View Nurse Directory

Request an Appointment

  • For adults:
    877-442-3324 (877-442-DFCI)
  • For children:
    888-733-4662 (888-PEDI-ONC)
  • Or complete the online form.

How Our Patients Rate Dana-Farber